本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Amphastar Pharmaceuticals

21.98
+0.46002.14%
盤後21.980.00000.00%19:30 EDT
成交量:28.38萬
成交額:618.65萬
市值:9.35億
市盈率:13.03
高:22.07
開:21.50
低:21.41
收:21.52
52周最高:31.26
52周最低:16.65
股本:4,253.79萬
流通股本:3,052.01萬
量比:0.81
換手率:0.93%
股息:- -
股息率:- -
每股收益(TTM):1.69
每股收益(LYR):2.03
淨資產收益率:10.30%
總資產收益率:5.11%
市淨率:1.22
市盈率(LYR):10.83

資料載入中...

2024/06/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/04

重要事件披露

Form 8-K - Current report
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/06

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/18

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities